Addiction Medicine
Latest News
Could semaglutide treat addiction as well as obesity?
“I would say, overall, the jury is still out,” as to whether anecdotal reports of GLP-1 agonists curbing addictions will be borne out in...
From the Journals
Alcohol dependence in teens tied to subsequent depression
There was no evidence that frequency or quantity of alcohol consumption at age 18 was significantly associated with depression at age 24.
From the Journals
How has cannabis legalization affected pregnant mothers?
“People who use cannabis during pregnancy often state that it was used to manage challenging symptoms of pregnancy such as morning sickness,” said...
Conference Coverage
Higher buprenorphine doses help OUD patients stay in treatment
Opioid users stick around when they get more withdrawal relief, addiction clinic finds.
Conference Coverage
Buprenorphine update: Looser rules and a helpful injectable
As overdose epidemic continues, new regulations change landscape for opioid addiction therapy.
Latest News
Exercise and empathy can help back pain patients in primary care
Recent research suggests limited pain relief from analgesics and antidepressants, but patients report that doctors’ behavior makes a difference in...
Practice Alert
Talking tobacco with youth? Ask the right questions
Children and adolescents in the United States are smoking cigarettes less—but use of “vapes” is taking their place. Effective prevention starts...
News from the FDA/CDC
FDA approves buprenorphine injection for opioid use disorder
Brixadi is approved in both weekly and monthly subcutaneous injectable formulations at varying doses.
News from the FDA/CDC
Overdose deaths mark another record year, but experts hopeful
“But these numbers are still extraordinarily high. We shouldn’t suggest the crisis is in any way over.”
Commentary
Balancing needs and risks as the opioid pendulum swings
The CDC encourages clinicians to find a balance of the potential benefits and harms and to avoid inflexibility.
News from the FDA/CDC
FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.